aibioNasdaq files Form 25 to delist ZyVersa Therapeutics common stock
Tickers ZVSA
The Nasdaq Stock Market LLC filed the notice with the SEC on October 6, 2025, citing the rule an exchange uses to remove a security.
Key facts
- Company
- ZyVersa Therapeutics, Inc. (OTC: ZVSA)
- News type
- Listings
- Primary source
- ZyVersa Therapeutics, Inc. 25-NSE (2025-10-06)
The Nasdaq Stock Market LLC filed a Form 25-NSE with the Securities and Exchange Commission on October 6, 2025 to remove the common stock of ZyVersa Therapeutics, Inc. from listing on the exchange.
A Form 25 is the notice filed when a security is removed from an exchange's list. The 25-NSE version is filed by the exchange rather than by the company. The filing cites 17 CFR 240.12d2-2(b), the SEC rule under which an exchange can remove a security from listing and registration.
The notice came from a Hearings Advisor at Nasdaq, which points to a delisting that went through the exchange's hearings process. It covers ZyVersa's common stock, registered under SEC file number 001-41184. The company gives its address as 2200 N. Commerce Parkway, Suite 208, in Weston, Florida, and its phone number as (754) 231-1688.
The form is a one-page notice with no narrative about the removal.